Dzhangar Dzhumashev

Comprehensive study of the drug delivery properties of poly(l‐lactide)‐poly(ethylene glycol) nanoparticles in rats and tumor‐bearing mice

Arkadiy V. Zintchenko, Y. Shilov, V. Shalgunov, 2017, Journal of controlled release : official journal of the Controlled Release Society.

Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma

K. Mamchaoui, J. Rössler, M. Bernasconi, 2022, Cancers.

Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma

M. Heller, P. Bode, A. Uldry, 2023, International journal of molecular sciences.

Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma

B. Schäfer, F. Perez, P. Luciani, 2020, Cancers.

CAR T cells recognizing CD276 and Dual-CAR T cells against CD276/FGFR4 promote rhabdomyosarcoma clearance in an orthotopic mouse model

Dzhangar Dzhumashev, A. Timpanaro, Caroline Piccand, 2023 .

CAR T cells recognizing CD276 and Dual-CAR T cells against CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models

Dzhangar Dzhumashev, A. Timpanaro, Caroline Piccand, 2023, bioRxiv.

CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models

Dzhangar Dzhumashev, A. Timpanaro, Caroline Piccand, 2023, Journal of Experimental & Clinical Cancer Research.

Rapid liposomal formulation for nucleolin targeting to rhabdomyosarcoma cells.

Dzhangar Dzhumashev, A. Timpanaro, Caroline Piccand, 2023, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.